Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Metzger

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Molecular Cell|January 22, 2008
A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencingYue Zhao, Guillaume Lang, Saya Ito, et al.
Cell Reports|December 9, 2014
Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activityChangmeng Cai, Housheng Hansen He, Shuai Gao, et al.
Journal of Medicinal Chemistry|June 7, 2024
Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD<sup>+</sup>-Dependent Lysine Deacylase Sirtuin 2Arianna Colcerasa, Florian Friedrich, Jelena Melesina, et al.
Genes & Development|December 3, 2005
NIR is a novel INHAT repressor that modulates the transcriptional activity of p53Philip Hublitz, Natalia Kunowska, Ulrich P Mayer, et al.
Nature Communications|January 30, 2025
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growthYanhan Jia, Sheng Wang, Sylvia Urban, et al.
Future Medicinal Chemistry|August 31, 2016
Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1)Dmytro Ostrovskyi, Tobias Rumpf, Julia Eib, et al.
Molecular Cell|March 4, 2014
Phosphorylation of LSD1 by PKCα is crucial for circadian rhythmicity and phase resettingHye Jin Nam, Kyungjin Boo, Dongha Kim, et al.
Nature Structural & Molecular Biology|May 8, 2019
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cellsEric Metzger, Sheng Wang, Sylvia Urban, et al.
Cancer Research|September 9, 2017
KDM4 Inhibition Targets Breast Cancer Stem-like CellsEric Metzger, Stella S Stepputtis, Juliane Strietz, et al.
Leukemia|March 7, 2019
Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Molecular Cell|January 22, 2008
A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencingYue Zhao, Guillaume Lang, Saya Ito, et al.
Cell Reports|December 9, 2014
Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activityChangmeng Cai, Housheng Hansen He, Shuai Gao, et al.
Journal of Medicinal Chemistry|June 7, 2024
Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD<sup>+</sup>-Dependent Lysine Deacylase Sirtuin 2Arianna Colcerasa, Florian Friedrich, Jelena Melesina, et al.
Genes & Development|December 3, 2005
NIR is a novel INHAT repressor that modulates the transcriptional activity of p53Philip Hublitz, Natalia Kunowska, Ulrich P Mayer, et al.
Nature Communications|January 30, 2025
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growthYanhan Jia, Sheng Wang, Sylvia Urban, et al.
Future Medicinal Chemistry|August 31, 2016
Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1)Dmytro Ostrovskyi, Tobias Rumpf, Julia Eib, et al.
Molecular Cell|March 4, 2014
Phosphorylation of LSD1 by PKCα is crucial for circadian rhythmicity and phase resettingHye Jin Nam, Kyungjin Boo, Dongha Kim, et al.
Nature Structural & Molecular Biology|May 8, 2019
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cellsEric Metzger, Sheng Wang, Sylvia Urban, et al.
Cancer Research|September 9, 2017
KDM4 Inhibition Targets Breast Cancer Stem-like CellsEric Metzger, Stella S Stepputtis, Juliane Strietz, et al.
Leukemia|March 7, 2019
Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
Pageof 6